Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2022 Earnings Call Transcript

Operator: Good afternoon, and welcome to Spero Therapeutics Fourth Quarter and Year-End 2022 Financial Results Conference Call. .

Keep Reading →